More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...

Rapid advances in viral vectors, advanced plasmid DNA and oncology drive new expansion in global markets.Austin, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Gene Therapy Starting Materials Market Size & Growth ...

Waters Corporation (NYSE: WAT) today unveiled the Waters Xevo Charge Detection Mass Spectrometer (CDMS), delivering unmatched ...

Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...

Waters unveils charge detection MS technology to spur development of next-generation biotherapeutics: Our Bureau, Bengaluru Wednesday, October 15, 2025, 11:45 Hrs [IST] Waters unv ...

The Xevo CDMS enhances analysis of large biomolecules, crucial for next-gen therapeutics, using individual-particle mass measurement for molecules up to 150+ MDa. Electrostatic Linear Ion Trap (ELIT) ...

The global swine industry faces a persistent and evolving challenge from viral pathogens, foremost among them being Porcine ...

Russia's Sputnik V vaccine is 92% effective at protecting people from COVID-19 according to interim trial results, the country's sovereign wealth fund said on Wednesday, as Moscow rushes to keep pace ...

Please provide your email address to receive an email when new articles are posted on . Interferon lambda-encoding messenger RNA drug ETH47 was generally safe in healthy individuals. A phase 2a trial ...

Viral vectors are critical vehicles for the delivery of life-saving cell and gene therapies. Adeno-associated virus (AAV) and lentiviral vectors (LVV), two of the most widely used vector platforms, ...